4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) CEO David Kirn Sells 12,930 Shares
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) CEO David Kirn sold 12,930 shares of the business’s stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $23.10, for a total transaction of $298,683.00. Following the transaction, the chief executive officer now owns 1,059,153 shares in the […]
More Stories
Zhuzhou CRRC Times Electric Co., Ltd. (ZHUZY) to Issue Dividend of $0.43 on August 23rd
Zhuzhou CRRC Times Electric Co., Ltd. (OTCMKTS:ZHUZY – Get Free Report) declared a dividend on Saturday, June 8th, NASDAQ reports....
Zoomlion Heavy Industry Science and Technology Co., Ltd. to Issue Dividend of $0.35 (OTCMKTS:ZLIOY)
Zoomlion Heavy Industry Science and Technology Co., Ltd. (OTCMKTS:ZLIOY – Get Free Report) declared a dividend on Wednesday, June 19th,...
United Microelectronics Co. Declares Annual Dividend of $0.36 (NYSE:UMC)
United Microelectronics Co. (NYSE:UMC – Get Free Report) announced an annual dividend on Thursday, June 13th, Zacks reports. Shareholders of...
Agilent Technologies, Inc. (NYSE:A) Announces $0.24 Quarterly Dividend
Agilent Technologies, Inc. (NYSE:A – Get Free Report) announced a quarterly dividend on Wednesday, May 22nd, Wall Street Journal reports....
Laurentian Bank of Canada Announces Quarterly Dividend of $0.47 (TSE:LB)
Laurentian Bank of Canada (TSE:LB – Get Free Report) announced a quarterly dividend on Tuesday, July 2nd, Zacks reports. Investors...
Beyond, Inc. (NYSE:BYON) Short Interest Up 51.8% in June
Beyond, Inc. (NYSE:BYON – Get Free Report) saw a significant increase in short interest in the month of June. As...